We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
55 hedge funds and large institutions have $363M invested in Kiniksa Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 14
34% more funds holding
Funds holding: 41 → 55 (+14)
22% more capital invested
Capital invested by funds: $298M → $363M (+$65.2M)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
25.53% less ownership
Funds ownership: 117.03% → 91.5% (-26%)
Holders
55
Holders Change
+14
Holders Change %
+34.15%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
28
Increased
10
Reduced
10
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$20.3M |
| 2 |
BlackRock
New York
|
+$8.57M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.89M |
| 4 |
Millennium Management
New York
|
+$3.88M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.89M |
